Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD
NCT03388385 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2022-08-16
Summary
The purpose of this study is to investigate the effects of acute intravenous iron administration on the endothelial function in non-dialysis Chronic Kidney Disease stages G3-G5 patients with anemia and iron deficiency, in relation to changes in oxidative and nitrosative status.
Conditions
- Renal Anemia
- Iron Toxicity
- Oxidative Stress
- Endothelial Dysfunction
Interventions
- DRUG
-
Sodium Chloride 0.9% Intravenous Solution
Physiologic saline infusion will be infused in day 1.
- DRUG
-
Ferinject
Ferric carboxymaltose will be infused in day 2.
Sponsors & Collaborators
-
S.C. Sanador S.R.L
collaborator OTHER -
Carol Davila University of Medicine and Pharmacy
lead OTHER
Principal Investigators
-
Gabriel Mircescu, Professor · Carol Davila University of Medicine and Pharmacy
-
Cristina Capusa, Assoc. Prof. · Carol Davila University of Medicine and Pharmacy
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-09-20
- Primary Completion
- 2020-12-30
- Completion
- 2022-12-20
Countries
- Romania
Study Locations
More Related Trials
-
Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
NCT00255437 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Intravenous Iron Repletion on Renal Function in Patients With Iron Deficiency and Acute Kidney Injury
NCT05960227 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis
NCT00236964 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease
NCT02648347 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis Patients
NCT02198495 ·Status: COMPLETED ·Phase: PHASE4
-
Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
NCT00255424 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of BCD-066 Compared to Aranesp® for Anemia Treatment in Chronic Kidney Disease Patients
NCT02506868 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Two Iron Preparations on Protein in the Urine
NCT00354692 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia
NCT05691257 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease Patients
NCT06994065 ·Status: COMPLETED ·Phase: NA
-
Effect of Adding Lactoferrin on Oral Iron on Anemia in Chronic Kidney Disease Patients
NCT05900635 ·Status: UNKNOWN ·Phase: PHASE4
-
Changes in Iron Markers Following Iron Loading in Hemodialysis Patients
NCT00308490 ·Status: COMPLETED ·Phase: PHASE4
-
Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
NCT00994318 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents
NCT03140722 ·Status: TERMINATED ·Phase: PHASE2
-
Roxadustat for Anemia in Patients With CKD
NCT04502537 ·Status: UNKNOWN
-
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease
NCT03992066 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic Kidney Disease (DD-CKD)
NCT02892149 ·Status: COMPLETED ·Phase: PHASE3
-
Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)
NCT02232906 ·Status: COMPLETED ·Phase: PHASE4
-
2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.
NCT00223977 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia
NCT02128074 ·Status: COMPLETED ·Phase: PHASE2
-
VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
NCT00317239 ·Status: COMPLETED ·Phase: PHASE3
-
Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure
NCT00318812 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
NCT02968368 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating Agents
NCT05082584 ·Status: WITHDRAWN ·Phase: PHASE3
-
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Participants With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
NCT02865850 ·Status: COMPLETED ·Phase: PHASE3